Skip to main content

Research outputs

What type of research output do you want to show?

2025

NRF2 upregulation by CDDO-Me protects AC16 human cardiomyocytes against doxorubicin-induced toxicity.

Roberts, J. A., Batie, M., Ponsford, A. H., Poh, J., Hewitt, B. J., Botfield, H. F., . . . Sharma, P. (2025). NRF2 upregulation by CDDO-Me protects AC16 human cardiomyocytes against doxorubicin-induced toxicity.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 194, 118878. doi:10.1016/j.biopha.2025.118878

DOI
10.1016/j.biopha.2025.118878
Journal article

NRF2 upregulation by CDDO-Me protects AC16 human cardiomyocytes against doxorubicin-induced toxicity

DOI
10.1101/2025.09.10.675420
Preprint

2021

2020

2019

Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis

Fernandez-Mosquera, L., Yambire, K. F., Renata, C., Pereyra, L., Pabis, K., Ponsford, A. H., . . . Raimundo, N. (2019). Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis. Autophagy, 15(9), 1572-1591. doi:10.1080/15548627.2019.1586256

DOI
10.1080/15548627.2019.1586256
Journal article

2016

2015

Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways

Wardyn, J. D., Ponsford, A. H., & Sanderson, C. M. (2015). Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways. BIOCHEMICAL SOCIETY TRANSACTIONS, 43, 621-626. doi:10.1042/BST20150014

DOI
10.1042/BST20150014
Journal article